Whalesbook
Basically, IHH Healthcare ko India market bahut pasand hai, aur iska main pillar banega Fortis Healthcare. Isiliye ye log ₹2,500 crore ka bada investment karne wale hain next 3 saal mein. Aim hai ki 2030 tak India mein 10,000 beds ready ho jayen.
Ab Fortis Healthcare ki baat karein toh, IHH ke entry ke baad se iska stock kaafi bhaga hai. Jab IHH ne pehle invest kiya tha tab share price tha ₹170 ke aas paas, aur ab ye ₹788.75 ke level par hai. Analysts bhi is par 'Strong Buy' bol rahe hain aur target ₹1,079 de rahe hain, matlab 30% se zyada upside ka chance. Fortis ka EBITDA bhi 23-24% tak pahunch gaya hai aur revenue/EBITDA mein saal dar saal mid-teens aur mid-20s ki growth dikh rahi hai.
Lekin India ka healthcare market bhi ekdum solid competition wala hai. IHH ko Apollo Hospitals aur Max Healthcare jaise bade players se takkar leni padegi. Waise toh India ka healthcare market USD 178 billion ka hai aur badh raha hai insurance aur government schemes ki wajah se. IHH ka abhi Fortis mein 31% stake hai aur unka target 50% tak pahunchna hai, jiske liye open offer ya market se buying karni padegi.
Par sab kuch itna bhi easy nahi hai. Indian hospital chains, jisme Fortis bhi hai, 60-65 ke P/E ratio par trade ho rahe hain, matlab future growth already priced in hai. IHH ko apne 31% stake ko 50% tak le jaane mein regulatory hurdles aa sakti hain. Aur companies ko merge karna aur doctors ko retain karna bhi ek bada challenge hota hai.
Overall, analysts IHH Healthcare par positive hain, target MYR 9.81 de rahe hain. Fortis ka target bhi ₹1,079 hai. India mein healthcare ki demand toh badh hi rahi hai. Ab dekhte hain IHH kaise apne plans execute karta hai aur competitors ko face karta hai.